TipRanks
Go Ultimate55% OFF

Ligand Pharma (LGND) Balance Sheet

Ligand Pharma Balance Sheet

Ligand Pharma's total assets for Q3 2026 were $2.24B, an increase of 2.36% from the previous quarter. LGND total liabilities were $1.28B for the fiscal quarter, a 4.71% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 1.56B$ 941.77M$ 787.22M$ 762.67M$ 1.30B
$ 543.42M$ 111.33M$ 86.30M$ 165.18M$ 476.43M
$ 1.02B$ 830.44M$ 700.91M$ 597.49M$ 821.16M

Currency in USD

Ligand Pharma Debt to Assets

0600M1.2B1.8B0 %20 %40 %60 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets